Reports from National Center for Immunization and Respiratory Diseases Describe Recent Advances in COVID-19 (Influenza, Covid-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults – United States, Fall 2024): Coronavirus – COVID-19

2025 APR 04 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Daily -- Investigators publish new report on Coronavirus - COVID-19. According to news reporting out of Atlanta, Georgia, by NewsRx editors, research stated, “The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza and COVID-19 vaccination for all persons aged >= 6 months, including adults aged >= 18 years. ACIP also recommends a single lifetime dose of respiratory syncytial virus (RSV) vaccine for adults aged >= 75 years and for those aged 60-74 years who are at increased risk for severe RSV disease.”

Our news journalists obtained a quote from the research from National Center for Immunization and Respiratory Diseases, “Data from the National Immunization Survey-Adult COVID Module, a random-digit-dialed cellular telephone survey of U.S. adults aged >= 18 years, are used to monitor influenza, COVID-19, and RSV vaccination coverage. By the week ending November 9, 2024, an estimated 34.7% of adults aged >= 18 years reported having received an influenza vaccine, and 17.9% reported having received a COVID-19 vaccine for the 2024-25 respiratory virus season; 39.7% of adults aged >= 75 years, and 31.6% of adults aged 60-74 years at increased risk for severe RSV, had ever received an RSV vaccine. Coverage varied by jurisdiction and demographic characteristics and was lowest among younger adults and those without health insurance. Although early season estimates indicate that many adults are unprotected from respiratory virus infections, many appeared open to vaccination: overall, approximately 35% and 41% of adults aged >= 18 years reported that they definitely or probably will receive or were unsure about receiving influenza and COVID-19 vaccines, respectively, and 40% of adults aged >= 75 years reported that they definitely or probably will receive or were unsure about receiving RSV vaccine. Health care providers and immunization programs still have time to expand outreach activities and promote vaccination to increase coverage in preparation for the height of the respiratory virus season.”

According to the news editors, the research concluded: “Using these data can help health care providers and immunization programs identify undervaccinated populations and understand vaccination patterns to guide planning, implementation, and evaluation of vaccination activities.”

This research has been peer-reviewed.

For more information on this research see: Influenza, Covid-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2024. Mmwr-morbidity and Mortality Weekly Report, 2024;73(46):1044-1051. Mmwr-morbidity and Mortality Weekly Report can be contacted at: Centers Disease Control & Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA.

Our news journalists report that additional information may be obtained by contacting Jennifer L. Kriss, Centers for Disease Control and Prevention, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Atlanta, GA 30329, United States. Additional authors for this research include Carla L. Black, Hilda Razzaghi, Mehreen Meghani, Ashley Tippins, Tammy A. Santibanez, Shannon Stokley, Kevin Chatham-Stephens, Nicole F. Dowling, Georgina Peacock and James A. Singleton.

(Our reports deliver fact-based news of research and discoveries from around the world.)